Single-dose of adrecizumab versus placebo in acute cardiogenic shock (ACCOST-HH): an investigator-initiated, randomised, double-blinded, placebo-controlled, multicentre trial
収録刊行物
-
- The Lancet Respiratory Medicine
-
The Lancet Respiratory Medicine 10 (3), 247-254, 2022-03
Elsevier BV